Fulgent Genetics director granted 11,117 RSUs
Dong Linda reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dong Linda reported acquisition or exercise transactions in this Form 4 filing.
Fulgent Genetics director Linda Dong reported receiving 11,117 shares of Common Stock as a grant of restricted stock units at no cash cost. The award vests over four years, with 1/4 vesting 12 months after May 14, 2026 and the rest quarterly, leaving her with 38,758 directly held shares after the grant.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 11,117 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 14, 2026, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date.
Key Figures
Key Terms
Restricted stock units financial
vesting financial
transaction code A regulatory
non-derivative financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Fulgent Genetics (FLGT) report for Linda Dong?
Was Linda Dong’s Form 4 transaction in FLGT stock a market purchase or sale?
What is the vesting schedule for Linda Dong’s 11,117 FLGT restricted stock units?
AI-generated analysis. How Rhea-AI works. Not financial advice.